ID1 and breast cancer: To directly address whether manipulation of Id1 could alter breast cancer progression, Id1 was transiently knocked down in 4T1.13‐LucGFP mouse breast cancer cells via a combination of three Id1‐targeting siRNA duplexes (Fig. 6D).